Pub. Date : 2021 Jun 1
PMID : 33729835
4 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Increased ERK activation by addition of phorbol myristate acetate (PMA) also reduced inflammation-associated myotube atrophy, and increased the interaction between dystrophin and beta-dystroglycan, which was partially attenuated in the presence of a phosphomimetic mutation at dystrophin S3059. | Tetradecanoylphorbol Acetate | dystrophin, muscular dystrophy | Mus musculus |
| 2 | Increased ERK activation by addition of phorbol myristate acetate (PMA) also reduced inflammation-associated myotube atrophy, and increased the interaction between dystrophin and beta-dystroglycan, which was partially attenuated in the presence of a phosphomimetic mutation at dystrophin S3059. | Tetradecanoylphorbol Acetate | dystrophin, muscular dystrophy | Mus musculus |
| 3 | Increased ERK activation by addition of phorbol myristate acetate (PMA) also reduced inflammation-associated myotube atrophy, and increased the interaction between dystrophin and beta-dystroglycan, which was partially attenuated in the presence of a phosphomimetic mutation at dystrophin S3059. | Tetradecanoylphorbol Acetate | dystrophin, muscular dystrophy | Mus musculus |
| 4 | Increased ERK activation by addition of phorbol myristate acetate (PMA) also reduced inflammation-associated myotube atrophy, and increased the interaction between dystrophin and beta-dystroglycan, which was partially attenuated in the presence of a phosphomimetic mutation at dystrophin S3059. | Tetradecanoylphorbol Acetate | dystrophin, muscular dystrophy | Mus musculus |